About
Akos Czibere has served as Aktis Oncology's Chief Medical Officer since July 2024. From 2017 to 2024 he held roles of increasing responsibility at Pfizer, most recently as Vice President and Therapeutic Area Head of Hematology-Oncology, and earlier held senior positions at Merrimack Pharmaceuticals. He holds an MD and PhD from the University of Duesseldorf, Germany, and completed a postdoctoral fellowship at Harvard Medical School.
Roles
Aktis Oncology, Inc.
Chief Medical Officer · Current role
July 2024–present
Pfizer
Vice President, Therapeutic Area Head of Hematology-Oncology · Responsible for strategy and execution across multiple programs
April 2017 - July 2024
Merrimack Pharmaceuticals
Roles of increasing seniority
—
Fixed Compensation
FY 2025Salary
$468,000
ComponentAnnual base salary earned in FY2025
All other compensation
$102,280
ComponentAll other compensation
Total compensation
$902,680
Performance Compensation
Data from FY 2025Cash incentive
Nonequity incentive plan compensation
$106,650
Target Opportunity
—
PlanAnnual bonus program
Stock awards
Option awards
$225,750
FormOption awards, ASC 718 grant-date fair value
Also at Aktis Oncology, Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.